跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
维莫思 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Moxifloxacin Hydrochloride Eye Drops
Approved
化学药品
Moxifloxacin Hydrochloride Eye Drops
NOVARTIS PHARMACEUTICALS CORPORATION
🇨🇳 National Medical Products Administration
Approval Date
Jul 4, 2023
Approval ID
8TEMKDeaLch
Company
NOVARTIS PHARMACEUTICALS CORPORATION
Type
化学药品
Approval Details
Approval Id
8TEMKDeaLch
Approval Number
国药准字HJ20180089
Generic Name
盐酸莫西沙星滴眼液
Generic Name En
Moxifloxacin Hydrochloride Eye Drops
Brand Name
维莫思
Drug Type
化学药品
Dosage Form
眼用制剂
Strength
按C₂₁H₂₄FN₃O₄计,5ml:25mg(0.5%,w/v)
Reg Date
2023-07-04
Expired Date
2028-07-03
Company Name
NOVARTIS PHARMACEUTICALS CORPORATION
Production Company Name
ALCON RESEARCH, LLC
Company Detail Path
/organization/novartis-pharmaceuticals-corporation
Production Company Detail Path
/organization/alcon-research-llc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jul 4, 2023
Approval ID
8TEMKDeaLch
Type
化学药品
Back to NMPA Approvals